{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T21:14:00Z","timestamp":1776719640953,"version":"3.51.2"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2013,5,24]],"date-time":"2013-05-24T00:00:00Z","timestamp":1369353600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Treat Options Neurol"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1007\/s11940-013-0241-x","type":"journal-article","created":{"date-parts":[[2013,5,23]],"date-time":"2013-05-23T13:19:52Z","timestamp":1369315192000},"page":"396-409","source":"Crossref","is-referenced-by-count":9,"title":["Treatment of Restless Legs Syndrome"],"prefix":"10.1007","volume":"15","author":[{"given":"Silvia","family":"Rios Romenets","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald B.","family":"Postuma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,5,24]]},"reference":[{"key":"241_CR1","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S1389-9457(03)00010-8","volume":"4","author":"RP Allen","year":"2003","unstructured":"Allen RP, Picchietti D, Hening WA, et al. Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Med. 2003;4:101\u201319.","journal-title":"Sleep Med"},{"key":"241_CR2","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.sleep.2005.03.008","volume":"6","author":"B Bjorvatn","year":"2005","unstructured":"Bjorvatn B, Leissner L, Ulfberg J, et al. Prevalence, severity and risk factors of restless legs syndrome in the general adult population in two Scandinavian countries. Sleep Med. 2005;6:307\u201312.","journal-title":"Sleep Med"},{"key":"241_CR3","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1001\/archinte.164.2.196","volume":"164","author":"K Berger","year":"2004","unstructured":"Berger K, Luedemann J, Trenkwalder C, John U, Kessler C. Sex and the risk of restless legs syndrome in the general population. Arch Intern Med. 2004;164:196\u2013202.","journal-title":"Arch Intern Med"},{"key":"241_CR4","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.sleep.2004.01.004","volume":"5","author":"M Zucconi","year":"2004","unstructured":"Zucconi M, Ferini-Strambi L. Epidemiology and clinical findings of restless legs syndrome. Sleep Med. 2004;5:293\u20139.","journal-title":"Sleep Med"},{"key":"241_CR5","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nrneurol.2010.55","volume":"6","author":"C Trenkwalder","year":"2010","unstructured":"Trenkwalder C, Paulus W. Restless legs syndrome: pathophysiology, clinical presentation and management. Nat Rev Neurol. 2010;6:337\u201346.","journal-title":"Nat Rev Neurol"},{"key":"241_CR6","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/ana.10282","volume":"52","author":"J Winkelmann","year":"2002","unstructured":"Winkelmann J, Muller-Myhsok B, Wittchen HU, et al. Complex segregation analysis of restless legs syndrome provides evidence for an autosomal dominant mode of inheritance in early age at onset families. Ann Neurol. 2002;52:297\u2013302.","journal-title":"Ann Neurol"},{"key":"241_CR7","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S1389-9457(99)00012-X","volume":"1","author":"RP Allen","year":"2000","unstructured":"Allen RP, Earley CJ. Defining the phenotype of the restless legs syndrome (RLS) using age-of-symptom-onset. Sleep Med. 2000;1:11\u20139.","journal-title":"Sleep Med"},{"key":"241_CR8","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1212\/01.wnl.0000336341.72621.db","volume":"72","author":"E Hattan","year":"2009","unstructured":"Hattan E, Chalk C, Postuma RB. Is there a higher risk of restless legs syndrome in peripheral neuropathy? Neurology. 2009;72:955\u201360.","journal-title":"Neurology"},{"key":"241_CR9","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1093\/sleep\/22.7.901","volume":"22","author":"WA Hening","year":"1999","unstructured":"Hening WA, Walters AS, Wagner M, et al. Circadian rhythm of motor restlessness and sensory symptoms in the idiopathic restless legs syndrome. Sleep. 1999;22:901\u201312.","journal-title":"Sleep"},{"key":"241_CR10","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1002\/1531-8257(199901)14:1<102::AID-MDS1017>3.0.CO;2-E","volume":"14","author":"C Trenkwalder","year":"1999","unstructured":"Trenkwalder C, Hening WA, Walters AS, et al. Circadian rhythm of periodic limb movements and sensory symptoms of restless legs syndrome. Mov Disord. 1999;14:102\u201310.","journal-title":"Mov Disord"},{"key":"241_CR11","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1002\/ana.10843","volume":"55","author":"M Michaud","year":"2004","unstructured":"Michaud M, Dumont M, Selmaoui B, et al. Circadian rhythm of restless legs syndrome: relationship with biological markers. Ann Neurol. 2004;55:372\u201380.","journal-title":"Ann Neurol"},{"issue":"Suppl 18","key":"241_CR12","doi-asserted-by":"crossref","first-page":"S476","DOI":"10.1002\/mds.21610","volume":"22","author":"D Garcia-Borreguero","year":"2007","unstructured":"Garcia-Borreguero D, Allen RP, Benes H, et al. Augmentation as a treatment complication of restless legs syndrome: concept and management. Mov Disord. 2007;22 Suppl 18:S476\u201384.","journal-title":"Mov Disord"},{"key":"241_CR13","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.sleep.2004.01.012","volume":"5","author":"R Allen","year":"2004","unstructured":"Allen R. Dopamine and iron in the pathophysiology of restless legs syndrome (RLS). Sleep Med. 2004;5:385\u201391.","journal-title":"Sleep Med"},{"key":"241_CR14","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1212\/01.WNL.0000078887.16593.12","volume":"61","author":"JR Connor","year":"2003","unstructured":"Connor JR, Boyer PJ, Menzies SL, et al. Neuropathological examination suggests impaired brain iron acquisition in restless legs syndrome. Neurology. 2003;61:304\u20139.","journal-title":"Neurology"},{"key":"241_CR15","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1038\/ng2099","volume":"39","author":"J Winkelmann","year":"2007","unstructured":"Winkelmann J, Schormair B, Lichtner P, et al. Genome-wide association study of restless legs syndrome identifies common variants in three genomic regions. Nat Genet. 2007;39:1000\u20136.","journal-title":"Nat Genet"},{"key":"241_CR16","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1016\/j.clinph.2004.01.031","volume":"115","author":"C Trenkwalder","year":"2004","unstructured":"Trenkwalder C, Paulus W. Why do restless legs occur at rest? Pathophysiology of neuronal structures in RLS. Neurophysiology of RLS (part 2). Clin Neurophysiol. 2004;115:1975\u201388.","journal-title":"Clin Neurophysiol"},{"key":"241_CR17","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/S1474-4422(06)70576-2","volume":"5","author":"W Paulus","year":"2006","unstructured":"Paulus W, Trenkwalder C. Less is more: pathophysiology of dopaminergic-therapy-related augmentation in restless legs syndrome. Lancet Neurol. 2006;5:878\u201386.","journal-title":"Lancet Neurol"},{"key":"241_CR18","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1529-8027.2007.00116.x","volume":"12","author":"F Gemignani","year":"2007","unstructured":"Gemignani F, Brindani F, Vitetta F, Marbini A, Calzetti S. Restless legs syndrome in diabetic neuropathy: a frequent manifestation of small fiber neuropathy. J Peripher Nerv Syst. 2007;12:50\u20133.","journal-title":"J Peripher Nerv Syst"},{"key":"241_CR19","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1212\/WNL.55.8.1115","volume":"55","author":"M Polydefkis","year":"2000","unstructured":"Polydefkis M, Allen RP, Hauer P, et al. Subclinical sensory neuropathy in late-onset restless legs syndrome. Neurology. 2000;55:1115\u201321.","journal-title":"Neurology"},{"key":"241_CR20","doi-asserted-by":"crossref","unstructured":"Rios Romenets S, Dauvilliers Y, Cochen De Cock V, et al. Restless legs syndrome outside the blood-brain barrier - exacerbation by domperidone in Parkinson's disease. Parkinsonism Relat Disord. 2013;19:92\u20134.","DOI":"10.1016\/j.parkreldis.2012.07.019"},{"key":"241_CR21","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1093\/ageing\/23.3.200","volume":"23","author":"ST O'Keeffe","year":"1994","unstructured":"O'Keeffe ST, Gavin K, Lavan JN. Iron status and restless legs syndrome in the elderly. Age Ageing. 1994;23:200\u20133.","journal-title":"Age Ageing"},{"key":"241_CR22","first-page":"1039","volume":"35","author":"RN Aurora","year":"2012","unstructured":"Aurora RN, Kristo DA, Bista SR, et al. The treatment of restless legs syndrome and periodic limb movement disorder in adults-an update for 2012: practice parameters with an evidence-based systematic review and meta-analyses: an American Academy of Sleep Medicine Clinical Practice Guideline. Sleep. 2012;35:1039\u201362. This article provides an update of previous review of American Academy of Sleep Medicine in the treatments of RLS using a systematic literature review and meta-analyses.","journal-title":"Sleep"},{"key":"241_CR23","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1111\/j.1468-1331.2012.03853.x","volume":"19","author":"D Garcia-Borreguero","year":"2012","unstructured":"Garcia-Borreguero D, Ferini-Strambi L, Kohnen R, et al. European guidelines on management of restless legs syndrome: report of a joint task force by the European Federation of Neurological Societies, the European Neurological Society and the European Sleep Research Society. Eur J Neurol. 2012;19:1385\u201396. This article is the European guidelines, which provides recently revised evidence-based recommendations for the treatment for RLS.","journal-title":"Eur J Neurol"},{"key":"241_CR24","first-page":"81","volume":"33","author":"JR Cornelius","year":"2010","unstructured":"Cornelius JR, Tippmann-Peikert M, Slocumb NL, Frerichs CF, Silber MH. Impulse control disorders with the use of dopaminergic agents in restless legs syndrome: a case-control study. Sleep. 2010;33:81\u20137.","journal-title":"Sleep"},{"key":"241_CR25","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.parkreldis.2007.05.006","volume":"14","author":"WG Ondo","year":"2008","unstructured":"Ondo WG, Lai D. Predictors of impulsivity and reward seeking behavior with dopamine agonists. Parkinsonism Relat Disord. 2008;14:28\u201332.","journal-title":"Parkinsonism Relat Disord"},{"key":"241_CR26","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1097\/wnf.0b013e31804c780e","volume":"30","author":"ED Driver-Dunckley","year":"2007","unstructured":"Driver-Dunckley ED, Noble BN, Hentz JG, et al. Gambling and increased sexual desire with dopaminergic medications in restless legs syndrome. Clin Neuropharmacol. 2007;30:249\u201355.","journal-title":"Clin Neuropharmacol"},{"key":"241_CR27","doi-asserted-by":"crossref","first-page":"157","DOI":"10.2165\/00023210-200923020-00005","volume":"23","author":"SS O'Sullivan","year":"2009","unstructured":"O'Sullivan SS, Evans AH, Lees AJ. Dopamine dysregulation syndrome: an overview of its epidemiology, mechanisms and management. CNS Drugs. 2009;23:157\u201370.","journal-title":"CNS Drugs"},{"key":"241_CR28","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1212\/01.wnl.0000252368.25106.b6","volume":"68","author":"M Tippmann-Peikert","year":"2007","unstructured":"Tippmann-Peikert M, Park JG, Boeve BF, Shepard JW, Silber MH. Pathologic gambling in patients with restless legs syndrome treated with dopaminergic agonists. Neurology. 2007;68:301\u20133.","journal-title":"Neurology"},{"key":"241_CR29","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.parkreldis.2006.10.001","volume":"13","author":"J Quickfall","year":"2007","unstructured":"Quickfall J, Suchowersky O. Pathological gambling associated with dopamine agonist use in restless legs syndrome. Parkinsonism Relat Disord. 2007;13:535\u20136.","journal-title":"Parkinsonism Relat Disord"},{"key":"241_CR30","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s11940-009-0036-2","volume":"11","author":"AM Williams","year":"2009","unstructured":"Williams AM, Garcia-Borreguero D. Management of restless legs syndrome augmentation. Curr Treat Options Neurol. 2009;11:327\u201332.","journal-title":"Curr Treat Options Neurol"},{"key":"241_CR31","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1007\/s00415-009-5299-8","volume":"257","author":"B Hogl","year":"2010","unstructured":"Hogl B, Garcia-Borreguero D, Kohnen R, et al. Progressive development of augmentation during long-term treatment with levodopa in restless legs syndrome: results of a prospective multi-center study. J Neurol. 2010;257:230\u20137.","journal-title":"J Neurol"},{"key":"241_CR32","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1212\/WNL.52.2.285","volume":"52","author":"V Collado-Seidel","year":"1999","unstructured":"Collado-Seidel V, Kazenwadel J, Wetter TC, et al. A controlled study of additional sr-L-dopa in L-dopa-responsive restless legs syndrome with late-night symptoms. Neurology. 1999;52:285\u201390.","journal-title":"Neurology"},{"key":"241_CR33","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.sleep.2010.12.007","volume":"12","author":"B Hogl","year":"2011","unstructured":"Hogl B, Garcia-Borreguero D, Trenkwalder C, et al. Efficacy and augmentation during 6\u00a0months of double-blind pramipexole for restless legs syndrome. Sleep Med. 2011;12:351\u201360.","journal-title":"Sleep Med"},{"key":"241_CR34","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1002\/mds.20257","volume":"19","author":"AS Walters","year":"2004","unstructured":"Walters AS, Ondo WG, Dreykluft T, et al. Ropinirole is effective in the treatment of restless legs syndrome. TREAT RLS 2: a 12-week, double-blind, randomized, parallel-group, placebo-controlled study. Mov Disord. 2004;19:1414\u201323.","journal-title":"Mov Disord"},{"key":"241_CR35","first-page":"92","volume":"75","author":"C Trenkwalder","year":"2004","unstructured":"Trenkwalder C, Garcia-Borreguero D, Montagna P, et al. Ropinirole in the treatment of restless legs syndrome: results from the TREAT RLS 1 study, a 12\u00a0week, randomized, placebo controlled study in 10 European countries. J Neurol Neurosurg Psychiatry. 2004;75:92\u20137.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"241_CR36","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.sleep.2006.09.009","volume":"8","author":"D Garcia-Borreguero","year":"2007","unstructured":"Garcia-Borreguero D, Grunstein R, Sridhar G, et al. A 52-week open-label study of the long-term safety of ropinirole in patients with restless legs syndrome. Sleep Med. 2007;8:742\u201352.","journal-title":"Sleep Med"},{"key":"241_CR37","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/S1474-4422(11)70127-2","volume":"10","author":"W Oertel","year":"2011","unstructured":"Oertel W, Trenkwalder C, Benes H, et al. Long-term safety and efficacy of rotigotine transdermal patch for moderate-to-severe idiopathic restless legs syndrome: a 5-year open-label extension study. Lancet Neurol. 2011;10:710\u201320. This is standard large and recent clinical trial, which test new option for treatment of moderate to severe primary RLS.","journal-title":"Lancet Neurol"},{"key":"241_CR38","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1159\/000008138","volume":"43","author":"BJ Davis","year":"2000","unstructured":"Davis BJ, Rajput A, Rajput ML, Aul EA, Eichhorn GR. A randomized, double-blind placebo-controlled trial of iron in restless legs syndrome. Eur Neurol. 2000;43:70\u20135.","journal-title":"Eur Neurol"},{"key":"241_CR39","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.sleep.2007.07.020","volume":"9","author":"C Trenkwalder","year":"2008","unstructured":"Trenkwalder C, Hogl B, Benes H, Kohnen R. Augmentation in restless legs syndrome is associated with low ferritin. Sleep Med. 2008;9:572\u20134.","journal-title":"Sleep Med"},{"key":"241_CR40","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.sleep.2011.06.009","volume":"12","author":"RP Allen","year":"2011","unstructured":"Allen RP, Adler CH, Du W, et al. Clinical efficacy and safety of IV ferric carboxymaltose (FCM) treatment of RLS: a multi-centered, placebo-controlled preliminary clinical trial. Sleep Med. 2011;12:906\u201313. This is a big, standard large and recent RCT's, which provides new option of treatment of RLS with intravenous iron salt.","journal-title":"Sleep Med"},{"key":"241_CR41","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.sleep.2004.03.002","volume":"5","author":"CJ Earley","year":"2004","unstructured":"Earley CJ, Heckler D, Allen RP. The treatment of restless legs syndrome with intravenous iron dextran. Sleep Med. 2004;5:231\u20135.","journal-title":"Sleep Med"},{"key":"241_CR42","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.sleep.2009.12.002","volume":"11","author":"WG Ondo","year":"2010","unstructured":"Ondo WG. Intravenous iron dextran for severe refractory restless legs syndrome. Sleep Med. 2010;11:494\u20136.","journal-title":"Sleep Med"},{"key":"241_CR43","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1038\/sj.ki.5002779","volume":"73","author":"M Auerbach","year":"2008","unstructured":"Auerbach M, Al TK. Low-molecular weight iron dextran and iron sucrose have similar comparative safety profiles in chronic kidney disease. Kidney Int. 2008;73:528\u201330.","journal-title":"Kidney Int"},{"key":"241_CR44","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1097\/00004850-199903000-00010","volume":"14","author":"J Horiguchi","year":"1999","unstructured":"Horiguchi J, Yamashita H, Mizuno S, et al. Nocturnal eating\/drinking syndrome and neuroleptic-induced restless legs syndrome. Int Clin Psychopharmacol. 1999;14:33\u20136.","journal-title":"Int Clin Psychopharmacol"},{"key":"241_CR45","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1097\/01.jcp.0000186870.75042.25","volume":"25","author":"NR Pinninti","year":"2005","unstructured":"Pinninti NR, Mago R, Townsend J, Doghramji K. Periodic restless legs syndrome associated with quetiapine use: a case report. J Clin Psychopharmacol. 2005;25:617\u20138.","journal-title":"J Clin Psychopharmacol"},{"key":"241_CR46","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1002\/hup.1130","volume":"25","author":"SG Kang","year":"2010","unstructured":"Kang SG, Park YM, Choi JE, et al. Association study between antipsychotic-induced restless legs syndrome and polymorphisms of monoamine oxidase genes in schizophrenia. Hum Psychopharmacol. 2010;25:397\u2013403.","journal-title":"Hum Psychopharmacol"},{"key":"241_CR47","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.pnpbp.2007.03.011","volume":"31","author":"SG Kang","year":"2007","unstructured":"Kang SG, Lee HJ, Jung SW, et al. Characteristics and clinical correlates of restless legs syndrome in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry. 2007;31:1078\u201383.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"241_CR48","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1093\/sleep\/33.10.1273","volume":"10","author":"RN Aurora","year":"2010","unstructured":"Aurora RN, Morgenthaler TI. On the goodness of recommendations: the changing face of practice parameters. Sleep. 2010;10:1273\u20136.","journal-title":"Sleep"}],"container-title":["Current Treatment Options in Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11940-013-0241-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11940-013-0241-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11940-013-0241-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T00:56:59Z","timestamp":1559437019000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11940-013-0241-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5,24]]},"references-count":48,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["241"],"URL":"https:\/\/doi.org\/10.1007\/s11940-013-0241-x","relation":{},"ISSN":["1092-8480","1534-3138"],"issn-type":[{"value":"1092-8480","type":"print"},{"value":"1534-3138","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,5,24]]}}}